VOXCAN part of IMPACT2 programme – an innovative translational AMR platform
VOXCAN, along with BioSystems Technology, BioVersys join forces to establish IMPACT2 - a breakthrough innovative translation AMR platform.
Read moreAlteVax – new member
AlteVax is developing and will bring to market an entirely new vaccine technology for cancer and infectious diseases.
Read moreGenopole – new member
Genopole, France’s leading biocluster for biotechnologies and research in genomics and genetics, unites innovative high-tech life sciences companies, public and private research and higher education facilities at a single site.
Read moreBIOMNIGENE – new member
Biomnigene is a company specialized in genomic services.
Read moreWYATT TECHNOLOGY – new member
Provider of separation and characterization solutions for biomacromolecules.
Read more